Physician profile
Jean Kuo
NPI 1508158262
$610.51
in general payments reported to CMS, 2019-2025
11 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $26.82 · 2021: $146 · 2022: $238 · 2023: $78.68 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $133.98 | 2021-2023 | Stelara |
| Astrazeneca Pharmaceuticals LP | $120.69 | 2025 | Lokelma |
| Dynavax Technologies Corporation | $115.58 | 2022 | |
| Intercept Pharmaceuticals, INC. | $53.36 | 2021-2023 | Ocaliva |
| Takeda Pharmaceuticals U.S.A., INC. | $52.83 | 2020-2022 | |
| Gilead Sciences, INC. | $36.70 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.16 | 2021-2023 | Xifaxan |
| Olympus America INC. | $22.23 | 2023 | Endocuff Vision |
| Csl Behring | $15.36 | 2021 | |
| Celgene Corporation | $13.08 | 2021 | |
| W. L. Gore & Associates, INC. | $12.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Kuo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.